Cefiderocol precursor 2 is a precursor to the synthesis of Cefiderocol (GSK-2696266D; S-649266; S-649266D; Fetroja), which is an injectable
siderophore cephalosporin antibiotic that has a catechol moiety on the
3-position of the side chain and was under clinical trials by Shionogi.